AMED: Amedisys, Inc. Stock

by  •  • Comments Off on AMED: Amedisys, Inc. Stock

SIC 8082 – Home Health Care Services

Valuation
Market Cap ($M) 3,064.70
Enterprise Value ($M) 3,167.79
Book Value ($M) 1,245.07
Book Value / Share 37.94
Price / Book 2.46
NCAV ($M) -305.54
NCAV / Share -9.31
Price / NCAV -10.03

Profitability (mra)
Return on Invested Capital (ROIC) 0.05
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.08

Liquidity (mrq)
Quick Ratio 1.29
Current Ratio 1.29

Balance Sheet (mrq) ($M)
Current Assets 633.96
Assets 2,184.57
Liabilities 939.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,348.32
Operating Income 209.57
Net Income 43.23
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 221.66
Cash from Investing -8.36
Cash from Financing -48.92

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 2 )
2025-04-24 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT
2025-02-28 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION RE
2024-07-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-23 30,080 116,708 25.77
2025-05-22 18,930 139,856 13.54
2025-05-21 71,902 390,407 18.42
2025-05-20 28,410 119,420 23.79
2025-05-19 34,656 198,230 17.48

(click for more detail)

Similar Companies
ADUS – Addus HomeCare Corporation AVAH – Aveanna Healthcare Holdings Inc.
BTSG – BrightSpring Health Services, Inc. OPCH – Option Care Health, Inc.


Financial data and stock pages provided by
Fintel.io